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Abbreviation 
 
Apo : apolipoprotein 
BSA : bovine serum albumin 
βVLDL : beta-very low density lipoprotein 
CCND : cyclin D 
CCNE : cyclin E 
CDK : cyclin dependent kinase 
CE : cholesteryl ester 
CMP : carbamoyl-PROXYL 
DMEM : Dulbecco's modified Eagle's medium 
EDTA : ethylenediaminetetraacetic acid 
FBS : fetal bovine serum 
FC : free cholesterol 
HCD : high cholesterol diet 
HDL : high density lipoprotein 
HRMC : human renal mesangial cell 
HRPTEC : human renal proximal tubular epithelial cell 
IgG : immunoglobulin G 
IP : inorganic phosphorus 
LDL : low density lipoprotein 
LDLR : low density lipoprotein receptor 
LRP : low density lipoprotein-related protein 
MRI : magnetic resonance imaging 
ND : normal diet 
PBS : phosphate-buffered saline 
PBS (+) : PBS containing Mg2+ and Ca2+ 
PFA : paraformaldehyde 
PL : phospholipid 
PPIB : peptidylprolyl isomerase B 
RT-PCR : real time polymerase chain reaction 
TC : total cholesterol 
Tris : 2-amino-2-(hydroxymethyl)propane-1,3-diol 
VLDL : very low density lipoprotein 
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Introduction 
Dyslipidemia is considered to be one of the onset and risk factors of not only 
cardiovascular disease, but also of the progression of renal failure in human chronic 
renal disease [1, 2]. It is reported that lipoprotein abnormalities aggravate renal injury 
via podocyte, a glomerulus epithelial cell, and that such podocyte injury is accompanied 
by tubulointerstitial cell activation and cell injury in animal models [3]. It is also known 
that elevated levels of lipids accelerate renal disease progression, which can be 
improved by a variety of manipulations that lower circulating lipids or prevent 
intracellular lipid accumulation [4-7]. High triglycerides, high non-high density 
lipoprotein (non-HDL) cholesterol, low HDL cholesterol, elevated total cholesterol (TC) 
and high apolipoprotein B (apoB) have been reported to influence the decline in renal 
function [8-11]. 
As the mechanism by which lipids affect kidneys, the lipid nephrotoxicity 
hypothesis proposed by Moorhead et al. in 1982 is widely supported [12]. According to 
Moorhead et al., circulating low density lipoprotein (LDL) binds with 
glycosaminoglycan in the glomerulus basement membrane and increases its 
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permeability. Lipid abnormalities is known to contribute to both atherosclerosis and 
glomerulosclerosis as cholesterol relocates to and accumulates in renal, vascular, 
hepatic and possibly other tissues [13]. It is reported that filtered lipoprotein 
accumulates in mesangial cells [12]. In glomerulus basal membrane disorder, 
lipoprotein is filtered and accumulates in mesangium cells, and stimulates proliferation 
and substrate production, leading to glomerulus hardening. In addition, the catabolism 
of the filtered lipoprotein in the renal tubule and the deposition of the apolipoprotein to 
the lumen result in the blockade of the nephron and promote stromal tissue failure. 
Diamond et al. proposed that the infiltration of the macrophage into the mesangium 
participates in the proliferation of mesangial cells, and the glomerulus capillary 
endothelial damage by the lipoprotein deteriorates the hemodynamics in the kidney, 
which lead to renal damage progression [14]. 
Megalin, or LDL receptor-related protein 2 (LRP2), is a member of the LDL 
receptor (LDLR) family and is an endocytic receptor expressed on the apical surface of 
several epithelial cells that internalizes a variety of ligands, such as insulin, albumin, 
hemoglobin, vitamin D-binding protein [15]. Megalin is considered to define the apical 
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recycling pathway of epithelial cells [16]. Megalin is reported to have an influence on 
the high protein absorption capacity of the kidney proximal tubule and on genetic 
proteinuric syndromes [16]. Megalin is involved in the uptake of drugs and toxic 
substances such as denatured protein, and also in the renal tubule cell disorder by the 
excessive load of plasma protein [17-19]. 
Most studies about renal damage due to hyperlipidemia have been conducted 
using animal disease models [20], and there are only a few high-cholesterol diet (HCD) 
fed models. Tomizawa et al. [21] have reported a change in renal function by magnetic 
resonance imaging (MRI) analysis in the kidneys of HCD induced kidney dysfunction 
mice [22, 23]. HCD mice showed significantly higher levels of blood urea nitrogen, 
creatinine and uric acid compared to the normal diet (ND) mice [24]. Using 
carbamoyl-PROXYL (CMP) as a contrast probe, the MRI signal increased after the 
injection of CMP in the ND mice, although in HCD mice, CMP-mediated enhancement 
peak of the MRI signal was not detected [24, 25]. Since CMP is neither secreted nor 
reabsorbed in the renal tubule, this MRI signal intensity is thought to reflect the quantity 
of glomerulus filtration. When the MRI signal intensity change was examined in 
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humans, the MRI signal peak was lower in patients with renal function failure compared 
to that of healthy humans. Because the results of hypercholesterolemia-mediated renal 
dysfunction mice were similar to the results of patients with renal function failure, there 
is a possibility that hypercholesterolemia induces renal disorder by the decrease of the 
quantity of glomerulus filtration. In addition, when the mice were treated with 
antilipidemic drugs (cholestyramine or ezetimibe), which lower cholesterol levels in the 
blood, CMP-mediated enhancement peak of the MRI signal appeared and the MRI 
signal seemed very similar to that of the ND mice. Therefore, there is a possibility that 
the increase in the blood cholesterol affects the renal dysfunction. 
It is considered that dyslipidemia causes renal damage. However, the detailed 
molecular mechanism has not been clarified and there are not many studies focusing on 
the effects of cholesterol. In the present study we examined the influence of cholesterol 
load on the function and the constitution of kidney cells by using mouse kidney tissue 
and kidney derived cultured cells. 
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Materials and Methods 
 
Histological examination of mouse kidneys 
Male C57BL/6 mice were fed ND or HCD (1.25% [w/w] 
cholesterol-containing hypercholesterol diet, Oriental Yeast Co.) for 11 weeks. After 11 
weeks, their kidneys were extracted and made into paraffin-embedded sections. After 
deparaffining of the section, we stained the sections by Masson’s trichrome staining.  
For immunohistology, we used megalin as a proximal tubule marker and 
examined the renal tubular change. We conducted immunostaining by using a 
VECTASTAIN Elite ABC kit (VECTOR) according to the manufacturer’s protocol. We 
used megalin polyclonal antibody (P-20, Santa Cruz Biotechnology) as the primary 
antibody and biotinylation secondary antibody [Anti-goat IgG (H+L)]. 
 
Western blot of megalin in mouse kidney homogenate and cultured cells 
We fed C57BL/6 mice on ND or HCD for 12 weeks. After 12 weeks, kidneys 
were extracted after perfusion, and 10 times the volume of IP buffer I [20 mM Tris-HCl 
(pH 7.4), 150 mM NaCl, 0.5% Triton X-100, 0.5% sodium deoxycholate, 10 mM EDTA, 
0.2% protease inhibitor cocktail] was added and homogenized with more than 
10 strokes. The supernatant was collected by centrifugation (9,000 g, 4°C, 10 min) and 
was used for Western blot analysis. 
For cultured cells, cells were collected by trypsin-EDTA solution treatment, 
centrifuged (1,000 rpm, 10 min), and dissolved in IP buffer II (20 mM Tris-HCl [pH 
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7.4], 150 mM NaCl, 0.5% Triton X-100, 0.5% sodium deoxycholate, 10 mM EDTA, 0.1 
mM FUT-175, 0.1 mM E-64-C, 0.5 mM Na3VO4, 5 mM NaF). After freeze-and-thaw, 
they were centrifuged (12,000 rpm, 20 min) and the supernatant was collected and was 
used for Western blot analysis.  
Western blot analysis was carried out using the megalin polyclonal antibody as 
described in histological examination. 
 
Effects of βVLDL on megalin in kidney derived cultured cells 
βVLDL was prepared by ultracentrifugation according to the method of 
Goldstein, et al. [1, 26] from blood of New Zealand White rabbits (Takasugi 
Experimental Animals Supply Co., Ltd.) fed RC-4 containing 1% cholesterol (Oriental 
Yeast Co.).  
For kidney derived cultured cells, we used an epithelial cell line originally 
derived from porcine kidneys, LLC-PK1 (DS Pharma Biomedical), a mouse renal 
mesangial cell line, SV40 MES 13 (ATCC), human renal mesangial cells, HRMC 
(ScienCell Research Laboratories) and human renal proximal tubular epithelial cells, 
HRPTEC (ScienCell Research Laboratories). We maintained LLC-PK1 in Dulbecco's 
modified Eagle's medium (DMEM) containing 3% fetal bovine serum (FBS, GIBCO), 
100 U/mL penicillin and 100 µg/mL streptomycin (Life Technologies Co.). MES 13 was 
cultured in DMEM containing 5% FBS, 100 U/mL penicillin and 100 µg/mL 
streptomycin. HRMC was maintained in Mesangial Cell Medium (ScienCell Research 
Laboratories) and HRPTEC was maintained in Epithelial Cell Medium (ScienCell 
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Research Laboratories). βVLDL was added at 0.2 mg TC/mL 1 day after the cells were 
plated. 
Total RNA was extracted using an RNeasy Mini Kit (QIAGEN) and the cDNA 
syntheses were performed using a High Capacity RNA-to-cDNA kit (Applied 
Biosystems). We performed a real-time quantitative PCR (RT-PCR) assay using an 
Applied Biosystems 7900 sequence detector with TaqMan Gene expression assays 
(Applied Biosystems) according to the manufacturer's protocol. The assay IDs for the 
Gene expression assays were as follows: human peptidylprolyl isomerase B (PPIB), 
Hs00168719_m1; human Megalin, Hs00189742_m1. Relative mRNA levels were 
normalized to PPIB mRNA levels. 
 
Effect of βVLDL on cellular proliferation 
LLC-PK1 and MES 13 were incubated with or without 0.2 mg TC/mL βVLDL 
for 1, 2 or 3 days. The cells were dyed with Trypan Blue Stain 0.4% (Life Technologies 
Co.) according to the manufacturer’s protocol. Then the cell number was counted to 
evaluate cellular proliferation.  
 
Effect of βVLDL on cell cycle-related genes 
 LLC-PK1 cells were incubated for 2 days with or without 0.2 mg TC/mL 
βVLDL. The effects of βVLDL on cell cycle-related gene were examined by RT-PCR 
using the Applied Biosystems 7900 sequence detector as described above. The assay 
IDs for the Gene expression assays were as follows: cyclin dependent kinase (CDK) 2; 
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Hs01548894_m1, CDK4; Hs00364847_m1, cyclin E1 (CCNE1); Hs01026536_m1, and 
cyclin D3 (CCND3); Hs00236949_m1. 
 
Effect of βVLDL on cholesterol accumulation 
For cholesterol accumulation, LLC-PK1 and MES 13 were plated in 6-well 
plates and treated with 0.2 mg TC/mL βVLDL for 2 days. After the βVLDL treatment, 
cells were washed with cold 0.1% BSA/PBS (+) and then PBS (+) and lipids were 
extracted using hexane:isopropanol (2:1, v/v). TC was measured using a Cholesterol 
E-test (Wako Pure Chemical Industries, Ltd), free cholesterol (FC) was measured using 
a Free cholesterol E-test (Wako Pure Chemical Industries, Ltd), and cholesteryl ester 
(CE) was calculated by subtracting FC from TC. 
 
Localization of neutral lipid and FC 
The intracellular distribution of neutral lipid after 2 days treatment with or 
without 0.2 mg TC/mL βVLDL was examined using Oil Red O staining. The cells were 
washed twice with PBS and fixed in 4% paraformaldehyde (PFA) for 10 min. Then they 
were washed twice with PBS, dyed with 60% Oil Red O for 20 min in room 
temperature, washed with Milli-Q water and 70% ethanol, dyed with Mayer’s 
hematoxylin solution for 2 min as counter staining and washed with Milli-Q water. The 
samples were enclosed with cover glasses after adding drops of CC/Mount TM. 
The intracellular distribution of FC after 2 days treatment with or without 0.2 
mg TC/mL βVLDL was examined using filipin staining. The cells were washed twice 
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with PBS and fixed in 4% PFA for 10 min. Then they were washed twice with PBS, 
dyed with Filipin solution for 1 h in room temperature and washed twice with PBS. The 
samples were enclosed with cover glasses after adding drops of CC/Mount TM. 
 
Dose-dependent accumulation of lipids 
LLC-PK1 and MES 13 were plated in 6-well plates and treated with 0, 0.2, 0.5, 
1 mg TC/mL βVLDL for 2 days. Lipids were extracted as described above and 
phospholipid (PL) was measured using a Phospholipid C-test (Wako Pure Chemical 
Industries, Ltd). 
 
Animal study 
The care, maintenance and experiments with animals were conducted in 
compliance with the guidelines of the Institutional Animal Care and Use Committee of 
Chiba University. 
 
Statistical analysis 
The results are expressed as the mean ± standard error (SE). Statistical analyses 
were conducted with SAS System Release 8.2 (SAS Institute Inc.). Comparisons 
between ND and HCD groups were performed with Student’s t test. A value of P < 0.05 
was considered significant. 
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Results 
 
Histological examination of mouse kidneys 
Male C57BL/6 mice were fed ND (Figures 1A, 1C) or HCD (Figures 1B, 1D) 
for 11 weeks. Representative micrographs show Masson’s trichrome staining (Figures 
1A, 1B). The gap between glomerulus and the surrounding Bowman’s capsule 
decreased in the kidney of the HCD mouse compared to that of ND mice. 
To examine the structural change of renal tubular cells, we performed an 
immunohistochemistry dyeing using megalin, which is a proximal tubule marker 
(Figures 1C, 1D). The expression of megalin in tubular epithelium lining the proximal 
tubules, which are contiguous to Bowman's capsule, decreased in the HCD mouse in 
comparison with the ND mouse. 
 
Western blot analysis of megalin in mouse kidney 
To examine the influence of HCD on the expression of megalin in kidney tissue, 
we used kidney tissues from male C57BL/6 mice fed ND (n=7) or HCD (n=7) for 12 
weeks. We used kidney extracts to determine the protein levels of megalin by Western 
blot analysis (Figure 2A). The bands of each group were quantified by densitometry 
(Figure 2B). HCD fed mice showed lower expression levels, but without significance. 
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Figure 1. Histological examination of mouse kidney.  
Male C57BL/6 mice were fed ND (A, C) or HCD (B, D) for 11 weeks. Representative 
micrographs show Masson’s trichrome staining (A, B) and immunostaining with 
megalin (proximal tubule marker, brown) and cellular nuclear staining (C, D). Box area 
is enlarged to compare HCD with ND (lower panels). Arrowhead: Bowman’s space, 
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arrow: expression of megalin in tubular epithelium lining the proximal tubules, which 
are contiguous to Bowman's capsule. Scale bars in panels: 50 μm.  
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Figure 2. Western blot analysis of megalin in mouse kidney.  
Male C57BL/6 mice (n = 7 per group) were fed ND or HCD for 12 weeks. Kidney 
extracts were used to determine the protein levels of megalin by Western blot analysis 
(A). The bands of each group were quantified by densitometry (B). Each bar represents 
the mean ± S.E., n.s.: not significant.  
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Effects of βVLDL on protein and mRNA levels of megalin in kidney derived cultured 
cells 
To consider whether lipoprotein load influences megalin expression in 
proximal tubule epithelium cells, LLC-PK1 cells were incubated for 1, 2, 3 or 4 days 
with or without 0.2 mg TC/mL βVLDL, and the expression of megalin was detected by 
Western blot analysis (Figure 3). As a result, there was less megalin expression in the 
βVLDL-loaded cells compared to untreated cells.  
To investigate the influence of lipoprotein load on renal mesangial cells and 
renal proximal tubular epithelial cells, HRMC and HRPTEC were treated with βVLDL 
for 2 days and the mRNA levels were quantified by RT-PCR (Figure 4). The mRNA 
levels of megalin were significantly reduced in both cells. 
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Figure 3. Western blot of megalin in kidney-derived cultured cells treated with 
βVLDL.  
LLC-PK1 cells were incubated with or without 0.2 mg TC/mL βVLDL for the indicated 
days. 
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Figure 4. Effect of βVLDL on mRNA levels of megalin in kidney derived cultured 
cells.  
HRMC cells (A) and HRPTEC cells (B) were incubated for 2 days with or without 0.2 
mg TC/mL βVLDL. Each bar represents the mean ± S.E. from triplicate, * P < 0.05, as 
compared with control group. 
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Effect of βVLDL on cellular proliferation 
We examined the influence of βVLDL on the cellular proliferation of MES 13 
(Figure 5A) and LLC-PK1 (Figure 5B). The cells were incubated with or without 0.2 
mg TC/mL βVLDL for 1, 2 or 3 days. The cell number increase of MES 13 did not 
change by treating with βVLDL, but the cell number of LLC-PK1 was significantly 
decreased.  
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Figure 5. Effect of βVLDL on cellular proliferation.  
Cells were incubated with or without 0.2 mg TC/mL βVLDL for the indicated number 
of days. □, without βVLDL; ■, with 0.2 mg TC/mL βVLDL. (A), MES 13 cells; (B), 
LLC-PK1 cells. Each point represents the mean ± S.E. from triplicates. * P < 0.05, ** P 
< 0.01, as compared with control.  
  
19 
 
Effect of βVLDL on cell cycle-related genes 
To investigate the mechanism of growth suppression by βVLDL in LLC-PK1, 
we evaluated the effect of βVLDL on cell cycle-related genes in renal proximal tubular 
epithelial cells. The mRNA levels of CDK2 and CCND3 in βVLDL-treated HRPTEC 
were significantly decreased compared to non-treated cells (Figure 6). 
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Figure 6. Effect of βVLDL on cell cycle-related genes in HRPTEC cells.  
RT-PCR of cell cycle-related genes in HRPTEC cells incubated with or without 
βVLDL. □, without βVLDL; ■, with 0.2 mg TC/mL βVLDL. Relative mRNA levels 
were normalized to PPIB mRNA levels. Each bar represents the mean ± S.E. from 
triplicates. ** P < 0.01, as compared with control. 
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Effect of βVLDL on cholesterol accumulation 
To investigate the mechanism of growth suppression by βVLDL in LLC-PK1, 
we checked the cholesterol accumulation on day 2, when the cell number difference was 
greatest, and compared it to that of MES 13 (Figure 7). The mean content of TC, FC and 
CE in βVLDL-treated MES 13 were 1.4-, 1.2- and 2.1-fold higher than non-treated cells, 
respectively. On the other hand, the mean content of TC, FC and CE in βVLDL-treated 
LLC-PK1 were 2.5-, 2.1- and 5.3-fold higher than non-treated cells, respectively. 
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Figure 7. Effect of βVLDL on cholesterol accumulation. 
Cells were incubated for 2 days with or without 0.2 mg TC/mL βVLDL. □, without 
βVLDL; ■, with 0.2 mg TC/mL βVLDL. Intracellular TC and FC were determined by 
enzymatic colorimetric assays (A, B). The concentration of CE was determined by 
subtracting FC from TC (C). Each bar represents the mean ± S.E. from triplicates. * P < 
0.05, ** P < 0.01, as compared with control.  
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Localization of neutral lipids and FC 
To investigate the localization of neutral lipids and FC that accumulated in the 
cells, we treated the cells with or without βVLDL for 2 days, and dyed the lipids with 
Oil Red O (Figure 8) and FC with filipin (Figure 9). In MES 13, more lipid accumulated 
near the nucleus. On the other hand, in LLC-PK1 the lipid scattered within the cell. In 
MES 13, FC was seen in both the cell membrane and cytoplasm, while FC was located 
more on the cell membrane in LLC-PK1.  
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Figure 8. Localization of neutral lipid in MES 13 and LLC-PK1 cells loaded with 
βVLDL. 
The intracellular distribution of neutral lipid was examined using Oil Red O staining. 
Cells were incubated for 2 days with or without 0.2 mg TC/mL βVLDL. Bar; 20 µm.  
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Figure 9. Localization of FC in MES 13 and LLC-PK1 cells loaded with βVLDL.  
The intracellular distribution of FC was examined using filipin staining. Cells were 
incubated for 2 days with or without 0.2 mg TC/mL βVLDL. Bar; 20 µm.
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Dose-dependent accumulation of lipids 
To consider the changes in the components of the cell membrane of LLC-PK1, 
in which the inhibition of the cell proliferation was seen by increased βVLDL load, we 
checked the changes in the amounts of PL, which is the main component of the cell 
membrane, and TC. In MES 13, the quantity of FC and PL was generally constant 
regardless of the concentration of the loaded βVLDL (Table 1). On the other hand, in 
LLC-PK1, FC and PL increased depending on the concentration of the loaded βVLDL. 
In addition, after calculating the molar ratio of FC for PL (FC/PL), the change of the 
value by the loaded βVLDL concentration was greater in LLC-PK1 than in MES 13. 
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Table 1. Dose-dependent accumulation of lipids in MES 13 and LLC-PK1 cells. 
 
 βVLDL FC PL FC/PL 
 (mg TC/mL) (μmol/mg protein) (μmol/mg protein) Molar Ratio 
MES 13 0.0 0.05 ± 0.00 0.09± 0.00 0.57 
 0.2 0.06 ± 0.00 0.08 ± 0.00 0.70 
 0.5 0.06 ± 0.01 0.08± 0.09 0.70 
 1.0 0.06 ± 0.00 0.08 ± 0.00 0.79 
LLC-PK1 0.0 0.04 ± 0.00 0.08 ± 0.00 0.51 
 0.2 0.06 ± 0.01 0.09 ± 0.01 0.68 
 0.5 0.12 ± 0.03 0.11 ± 0.03 1.04 
 1.0 0.11 ± 0.04 0.13 ± 0.05 0.86 
 
Cells were incubated with βVLDL for 2 days at the indicated dosage (0, 0.2, 0.5, 1.0 mg 
TC/mL βVLDL). FC and PL in MES 13 cells and LLC-PK1 cells was measured and 
FC-to-PL molar ratios of MES 13 and LLC-PK1 cells was calculated. Each value 
represents the mean ± S.E. from triplicates. An average PL molecular weight of 800 was 
used in determining PL-to-protein weight ratios.  
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Discussion 
In the kidney of the HCD mice, the gap between glomerulus and its 
surrounding Bowman’s capsule decreased compared to that of the ND mice (Figures 1A, 
1B). Tomizawa et al. have reported that HCD mice showed significantly higher levels of 
blood urea nitrogen, creatinine and uric acid compared to the ND mice [24]. Tomizawa 
et al. showed that the quantity of glomerulus filtration decreased in HCD mice. It is 
considered that the decrease in quantity of glomerulus filtration causes the filtration 
pressure of the remaining individual nephrons to rise [27], which may have affected the 
size of the gap between the glomerulus and its surrounding Bowman’s capsule. It is 
reported that the damage of podocyte causes leakage of protein from the basement 
membrane and induces further damage to the podocyte, causing loss of podocyte and 
leaving bare basement membrane. Parietal epithelial cells attach to the bare basement 
membrane which lead to the formation of a tuft adhesion to Bowman’s capsule [28, 29]. 
Le Hir and Kriz proposed that cellular adhesion was formed predominantly by injured 
podocytes [30]. From the above, there is a possibility that cholesterol overload decrease 
the gap between the glomerulus and the Bowman’s capsule enhancing the adhesion to 
Bowman’s capsule. 
In our study, the expression level of megalin in the Bowman’s capsule junction 
of the proximal tubule of HCD mice decreased compared to that of the ND mice 
(Figures 1C, 1D). Bowman’s capsule junction is the first part through which the 
primitive urine, after already having passed the glomerulus, flows into the renal tubule, 
and it is also the part that is most easily affected by the protein in the primitive urine. 
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Proteinuria is observed in megalin-deficient mice, therefore megalin is thought to take 
part in proximal tubule protein reabsorption of the glomerulus filtrated protein [18, 31]. 
The decrease of megalin which was observed in the Bowman’s capsule junction may 
have an effect on proximal tubule protein reabsorption, leading to renal function 
deterioration. 
We have reported that serum apoB-100, apoB-48 and apoE expression level 
was higher in HCD mice compared to ND mice. Since apoB-100, apoB-48 and apoE are 
the constituent of βVLDL [32, 33], we used βVLDL for treating the cells to evaluate the 
influence of cholesterol overload in kidney-derived cells. When we treated LLC-PK1 
with βVLDL, the expression level of megalin was lower than that of non-treated 
controls (Figure 3). The mRNA levels of megalin in HRPTEC and HRMC was also 
decreased by βVLDL treatment (Figure 4). It is reported that accumulation of 
cholesterol in the mesangial region causes glomerular sclerosis due to foam cell 
formation of mesangial cells and expansion of glomerulus basement membrane [34]. 
We found a decrease in megalin expression in HRMC, suggesting that the decrease in 
megalin affect the expansion of glomerulus basement membrane, leading to glomerular 
sclerosis. Taken together, it is considered that apoB and apoE, which are increased in 
blood by HCD feeding, leak into the primitive urine and they may be the reason for the 
decrease of megalin expression in the Bowman’s capsule junction. Since apoB and 
apoE are also ligands for megalin [19, 35], the decrease of megalin by βVLDL load may 
be one of the self-protective mechanisms of the renal tubule cells.  
Cellular proliferation was inhibited by βVLDL load in LLC-PK1 (Figure 5). 
30 
 
We considered the possibility that βVLDL might induce apoptosis in LLC-PK1. We 
checked the activation of caspase 3 and the fragmentation of DNA as an index of the 
apoptosis. However, treatment with βVLDL did not induce apoptosis in LLC-PK1. We 
also checked the effect of βVLDL on cell cycle progression in HRPTEC by RT-PCR of 
CDK and cyclin, and the mRNA levels of CDK4 and CCND3 was decreased (Figure 6). 
These results suggest that the decrease in the cell cycle-related genes may be 
responsible for the proliferation suppression by βVLDL in LLC-PK1. 
TC, FC and CE increased (Figure 7) and cholesterol accumulated in cells by 
βVLDL load in MES13 and LLC-PK1 cells (Figures 8, 9). In βVLDL-loaded MES 13, 
lipids accumulated near the nucleus, and in LLC-PK1 the lipids scattered within the cell 
(Figure 8). When we looked at FC, in MES 13, FC was seen in both cell membrane and 
cytoplasm, while in LLC-PK1, FC was located more in the cell membrane (Figure 9). In 
LLC-PK1, 60% of the increased TC by βVLDL load was FC (Table 1). The molar ratio 
of FC to PL (FC/PL) changed from 0.57 in non-treated cells to 0.79 in βVLDL loaded 
MES13, and from 0.51 to maximum of 1.04 in LLC-PK1 cells (Table 1). An increase in 
FC/PL is known to decrease membrane fluidity [36, 37], and cholesterol has been found 
to modulate the function of membrane proteins which are critical to cellular function 
[38]. Therefore, the accumulation of FC and the increase in the FC/PL may have also 
affected the suppression of the cell proliferation of LLC-PK1.  
In summary, cholesterol overload may influence chronic kidney disease and 
decrease renal function by increasing the amount of cholesterol taken up into the 
proximal tubular epithelial cells, decreasing megalin and causing suppression on cell 
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proliferation, which may be the cause of kidney damage.  
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Summary 
The purpose of this study was to examine the influence of cholesterol load on 
kidney function and the constitution of kidney cells. Dyslipidemia is one of the onset 
and risk factors of chronic kidney disease. It is reported that a renal function drop due to 
glomerulus hardening and renal tubule stroma obstacles is seen in high-fat diet fed 
animal models, and it is also said that lipid lowering therapy delays nephropathic 
progress in humans. Therefore, in this study we used mouse kidney tissue and kidney 
derived cultured cells to examine the influence of cholesterol overload. 
We examined the effect of cholesterol load on kidney by using mouse kidney 
tissue and kidney derived cultured cells. We detected a reduction in the gap between the 
glomerulus and the Bowman’s capsule of the HCD mice kidney compared to that of the 
ND mice. We also observed a decrease in megalin expression in the proximal tubule of 
HCD mice kidneys compared to that of the ND mice, suggesting that the increase of 
lipoprotein in the primitive urine may decrease the megalin expression in the proximal 
tubule epithelial cells. Since megalin functions to reabsorb various substances filtered 
from glomeruli and to promote their metabolism, there is a possibility that a decrease in 
the expression of megalin lowers such kidney function and leads to renal failure. 
When we tested a βVLDL load against LLC-PK1, the cell proliferation of 
LLC-PK1 was significantly decreased. Since FC/PL increase was seen in LLC-PK1, 
there is a possibility that βVLDL load decreases the membrane fluidity in LLC-PK1, 
leading to the suppression of cell proliferation in tubular epithelial cells.  
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Taken together, cholesterol overload may influence chronic kidney disease and 
decrease renal function by increasing the amount of cholesterol taken up into the 
proximal tubular epithelial cells, decreasing megalin and causing suppression on cell 
proliferation, which may be the cause of kidney damage.  
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